Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma

N. Kunkeaw, S. H. Jeon, K. Lee, B. H. Johnson, S. Tanasanvimon, M. Javle, C. Pairojkul, Y. Chamgramol, W. Wongfieng, Bin Gong, C. Leelayuwat, Y. S. Lee

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We have recently identified nc886 (pre-miR-886 or vtRNA2-1) as a novel type of non-coding RNA that inhibits activation of protein kinase R (PKR). PKR's pro-apoptotic role through eukaryotic initiation factor 2 a (eIF2a) phosphorylation is well established in the host defense against viral infection. Paradoxically, some cancer patients have elevated PKR activity; however, its cause and consequence are not understood. Initially, we evaluated the expression of nc886, PKR and eIF2a in non-malignant cholangiocyte and cholangiocarcinoma (CCA) cells. nc886 is repressed in CCA cells and this repression is the cause of PKR's activation therein.nc886 alone is necessary and sufficient for suppression of PKR via direct physical interaction. Consistently, artificial suppression of nc886 in cholangiocyte cells activates the canonical PKR/eIF2a cell death pathway, suggesting a potential significance of the nc886 suppression and the consequent PKR activation in eliminating pre-malignant cells during tumorigenesis. In comparison, active PKR in CCA cells does not inducephospho-eIF2a nor apoptosis, but promotes the pro-survival nuclear factor-kB pathway. Thus, PKR has a dual life or death role during tumorigenesis. Similarly to the CCA cell lines, nc886 tends to be decreased but PKR tends to be activated in our clinical samples from CCA patients. Collectively from our data, we propose a tumor surveillance model for nc886's role in the PKR pathway during tumorigenesis.

Original languageEnglish (US)
Pages (from-to)3722-3731
Number of pages10
JournalOncogene
Volume32
Issue number32
DOIs
StatePublished - Aug 8 2013

Fingerprint

Untranslated RNA
Cholangiocarcinoma
Protein Kinases
Cell Death
Cell Proliferation
Eukaryotic Initiation Factor-2
Carcinogenesis
Virus Diseases
Neoplasms
Phosphorylation
Apoptosis
Cell Line

Keywords

  • cholangiocarcinoma
  • eIF2a
  • nc886
  • NF-kB
  • PKR

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Kunkeaw, N., Jeon, S. H., Lee, K., Johnson, B. H., Tanasanvimon, S., Javle, M., ... Lee, Y. S. (2013). Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene, 32(32), 3722-3731. https://doi.org/10.1038/onc.2012.382

Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. / Kunkeaw, N.; Jeon, S. H.; Lee, K.; Johnson, B. H.; Tanasanvimon, S.; Javle, M.; Pairojkul, C.; Chamgramol, Y.; Wongfieng, W.; Gong, Bin; Leelayuwat, C.; Lee, Y. S.

In: Oncogene, Vol. 32, No. 32, 08.08.2013, p. 3722-3731.

Research output: Contribution to journalArticle

Kunkeaw, N, Jeon, SH, Lee, K, Johnson, BH, Tanasanvimon, S, Javle, M, Pairojkul, C, Chamgramol, Y, Wongfieng, W, Gong, B, Leelayuwat, C & Lee, YS 2013, 'Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma', Oncogene, vol. 32, no. 32, pp. 3722-3731. https://doi.org/10.1038/onc.2012.382
Kunkeaw, N. ; Jeon, S. H. ; Lee, K. ; Johnson, B. H. ; Tanasanvimon, S. ; Javle, M. ; Pairojkul, C. ; Chamgramol, Y. ; Wongfieng, W. ; Gong, Bin ; Leelayuwat, C. ; Lee, Y. S. / Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. In: Oncogene. 2013 ; Vol. 32, No. 32. pp. 3722-3731.
@article{938bad25126e4b74ba5da424ac9207d2,
title = "Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma",
abstract = "We have recently identified nc886 (pre-miR-886 or vtRNA2-1) as a novel type of non-coding RNA that inhibits activation of protein kinase R (PKR). PKR's pro-apoptotic role through eukaryotic initiation factor 2 a (eIF2a) phosphorylation is well established in the host defense against viral infection. Paradoxically, some cancer patients have elevated PKR activity; however, its cause and consequence are not understood. Initially, we evaluated the expression of nc886, PKR and eIF2a in non-malignant cholangiocyte and cholangiocarcinoma (CCA) cells. nc886 is repressed in CCA cells and this repression is the cause of PKR's activation therein.nc886 alone is necessary and sufficient for suppression of PKR via direct physical interaction. Consistently, artificial suppression of nc886 in cholangiocyte cells activates the canonical PKR/eIF2a cell death pathway, suggesting a potential significance of the nc886 suppression and the consequent PKR activation in eliminating pre-malignant cells during tumorigenesis. In comparison, active PKR in CCA cells does not inducephospho-eIF2a nor apoptosis, but promotes the pro-survival nuclear factor-kB pathway. Thus, PKR has a dual life or death role during tumorigenesis. Similarly to the CCA cell lines, nc886 tends to be decreased but PKR tends to be activated in our clinical samples from CCA patients. Collectively from our data, we propose a tumor surveillance model for nc886's role in the PKR pathway during tumorigenesis.",
keywords = "cholangiocarcinoma, eIF2a, nc886, NF-kB, PKR",
author = "N. Kunkeaw and Jeon, {S. H.} and K. Lee and Johnson, {B. H.} and S. Tanasanvimon and M. Javle and C. Pairojkul and Y. Chamgramol and W. Wongfieng and Bin Gong and C. Leelayuwat and Lee, {Y. S.}",
year = "2013",
month = "8",
day = "8",
doi = "10.1038/onc.2012.382",
language = "English (US)",
volume = "32",
pages = "3722--3731",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "32",

}

TY - JOUR

T1 - Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma

AU - Kunkeaw, N.

AU - Jeon, S. H.

AU - Lee, K.

AU - Johnson, B. H.

AU - Tanasanvimon, S.

AU - Javle, M.

AU - Pairojkul, C.

AU - Chamgramol, Y.

AU - Wongfieng, W.

AU - Gong, Bin

AU - Leelayuwat, C.

AU - Lee, Y. S.

PY - 2013/8/8

Y1 - 2013/8/8

N2 - We have recently identified nc886 (pre-miR-886 or vtRNA2-1) as a novel type of non-coding RNA that inhibits activation of protein kinase R (PKR). PKR's pro-apoptotic role through eukaryotic initiation factor 2 a (eIF2a) phosphorylation is well established in the host defense against viral infection. Paradoxically, some cancer patients have elevated PKR activity; however, its cause and consequence are not understood. Initially, we evaluated the expression of nc886, PKR and eIF2a in non-malignant cholangiocyte and cholangiocarcinoma (CCA) cells. nc886 is repressed in CCA cells and this repression is the cause of PKR's activation therein.nc886 alone is necessary and sufficient for suppression of PKR via direct physical interaction. Consistently, artificial suppression of nc886 in cholangiocyte cells activates the canonical PKR/eIF2a cell death pathway, suggesting a potential significance of the nc886 suppression and the consequent PKR activation in eliminating pre-malignant cells during tumorigenesis. In comparison, active PKR in CCA cells does not inducephospho-eIF2a nor apoptosis, but promotes the pro-survival nuclear factor-kB pathway. Thus, PKR has a dual life or death role during tumorigenesis. Similarly to the CCA cell lines, nc886 tends to be decreased but PKR tends to be activated in our clinical samples from CCA patients. Collectively from our data, we propose a tumor surveillance model for nc886's role in the PKR pathway during tumorigenesis.

AB - We have recently identified nc886 (pre-miR-886 or vtRNA2-1) as a novel type of non-coding RNA that inhibits activation of protein kinase R (PKR). PKR's pro-apoptotic role through eukaryotic initiation factor 2 a (eIF2a) phosphorylation is well established in the host defense against viral infection. Paradoxically, some cancer patients have elevated PKR activity; however, its cause and consequence are not understood. Initially, we evaluated the expression of nc886, PKR and eIF2a in non-malignant cholangiocyte and cholangiocarcinoma (CCA) cells. nc886 is repressed in CCA cells and this repression is the cause of PKR's activation therein.nc886 alone is necessary and sufficient for suppression of PKR via direct physical interaction. Consistently, artificial suppression of nc886 in cholangiocyte cells activates the canonical PKR/eIF2a cell death pathway, suggesting a potential significance of the nc886 suppression and the consequent PKR activation in eliminating pre-malignant cells during tumorigenesis. In comparison, active PKR in CCA cells does not inducephospho-eIF2a nor apoptosis, but promotes the pro-survival nuclear factor-kB pathway. Thus, PKR has a dual life or death role during tumorigenesis. Similarly to the CCA cell lines, nc886 tends to be decreased but PKR tends to be activated in our clinical samples from CCA patients. Collectively from our data, we propose a tumor surveillance model for nc886's role in the PKR pathway during tumorigenesis.

KW - cholangiocarcinoma

KW - eIF2a

KW - nc886

KW - NF-kB

KW - PKR

UR - http://www.scopus.com/inward/record.url?scp=84881480185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881480185&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.382

DO - 10.1038/onc.2012.382

M3 - Article

VL - 32

SP - 3722

EP - 3731

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 32

ER -